Serum Brain-derived Neurotrophic Factor Level Predicts Adverse Clinical Outcomes in Patients with Heart Failure.

MLA

Kudo, Masato, et al. “Serum Brain-Derived Neurotrophic Factor Level Predicts Adverse Clinical Outcomes in Patients with Heart Failure.” Journal of Cardiac Failure, vol. 20, no. 10, Oct. 2014, p. S207. EBSCOhost, https://doi.org/10.1016/j.cardfail.2014.07.414.

APA

Kudo, M., Kinugawa, S., Fukushima, A., Yokota, T., Matsushima, S., Furihata, T., Tsuda, M., Matsumoto, J., Takada, S., & Tsutsui, H. (2014). Serum Brain-derived Neurotrophic Factor Level Predicts Adverse Clinical Outcomes in Patients with Heart Failure. Journal of Cardiac Failure, 20(10), S207. https://doi.org/10.1016/j.cardfail.2014.07.414

Chicago

Kudo, Masato, Shintaro Kinugawa, Arata Fukushima, Takashi Yokota, Shouji Matsushima, Takaaki Furihata, Masaya Tsuda, Junichi Matsumoto, Shingo Takada, and Hiroyuki Tsutsui. 2014. “Serum Brain-Derived Neurotrophic Factor Level Predicts Adverse Clinical Outcomes in Patients with Heart Failure.” Journal of Cardiac Failure 20 (10): S207. doi:10.1016/j.cardfail.2014.07.414.